Cost of Sales
Breakdown
Segments
Tyvaso DPIView metric
Nebulized TyvasoView metric
RemodulinView metric
OrenitramView metric
UnituxinView metric
AdcircaView metric
OtherView metric
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Tyvaso DPI | $37.6M | $39.1M | $38.4M | $48.1M | $48.5M | $55.3M | $58.7M | $83.2M |
| Remodulin | $12.8M | $13.3M | $13.4M | $13.8M | $14.3M | $13.1M | $8.1M | $16.1M |
| Nebulized Tyvaso | $8.4M | $9.4M | $7.4M | $8.5M | $5.6M | $6.7M | $6.4M | $8.6M |
| Orenitram | $5.9M | $7.6M | $5.7M | $8.3M | $6.7M | $6.8M | $6.9M | $7.4M |
| Unituxin | $3.8M | $4.8M | $2.2M | $5.2M | $2.8M | $3.6M | $5.9M | $5M |
| Adcirca | $2.6M | $3.1M | $1.8M | $2.6M | $2.7M | $4.4M | $3.4M | $1M |
| Total | $77.8M | $83.1M | $75.9M | $92.5M | $87.6M | $100.9M | $103.4M | $133.4M |